[1]
Hewa, C.P. and Khan, Y. 2014. A case of delayed initial response to combination ipilimumab and nivolumab in malignant pleural mesothelioma. Trends in Immunotherapy. 8, 2 (Nov. 2014). DOI:https://doi.org/10.24294/ti8705.